Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Henry Onyeaka, M.B.,Ch.B.

Concepts (136)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Henry Onyeaka's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Henry Onyeaka has written about over time.
Suicide, Attempted, 4 publications between 2020 and 2023, average publication date September 2021. Suicidal Ideation, 9 publications between 2020 and 2023, average publication date December 2021. Crime Victims, 2 publications between 2021 and 2023, average publication date May 2022. Sex Offenses, 2 publications between 2021 and 2023, average publication date May 2022. Adolescent Behavior, 6 publications between 2021 and 2023, average publication date May 2022. Politics, 1 publications between 2023 and 2023, average publication date June 2023. Papillomavirus Infections, 3 publications between 2022 and 2023, average publication date June 2023. Papillomavirus Vaccines, 3 publications between 2022 and 2023, average publication date June 2023. Emigrants and Immigrants, 2 publications between 2022 and 2024, average publication date September 2023. Anesthetics, Local, 1 publications between 2024 and 2024, average publication date July 2024. Lidocaine, 1 publications between 2024 and 2024, average publication date July 2024. Television, 1 publications between 2024 and 2024, average publication date July 2024. Magnesium, 1 publications between 2024 and 2024, average publication date August 2024.

To see the data from this visualization as text, click here.
Onyeaka's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (136)
Explore
_
Co-Authors (33)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.